Skip to main content
logo
Corline Biomedical AB (STO:CLBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
17.60
+0.05 (0.28%)
Jul 24, 2026, 3:35 PM CET

Corline Biomedical AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
10.78.6217.6935.9333.3317.26
Revenue Growth
-25.06%-51.27%-50.78%7.80%93.09%14.29%
Gross Profit
8.866.2613.8628.7923.479.17
Operating Income
-14.18-14.75-23.17-1.792.33-6.91
Net Income
-14.14-14.71-23.19-1.812.33-6.92
Earnings Per Share
-0.56-0.59-1.06-0.080.11-0.34
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
32.920.5617.6717.0126.2141.64
Total Debt
000000
Net Cash (Debt)
32.920.5617.6717.0126.2141.64
Net Cash Growth
180.38%16.35%3.86%-35.09%-37.05%367.55%
Net Cash Per Share
1.320.830.810.791.192.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17.51-17.69-8.640.89-6.45-4.84
Capital Expenditures
-0.4-0.05--0.13-0.15-0.14
Free Cash Flow
-17.91-17.74-8.640.75-6.61-4.98
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
82.85%72.62%78.34%80.13%70.40%53.12%
Operating Margin
-132.60%-171.16%-130.98%-4.98%6.99%-40.02%
Pretax Margin
-132.24%-170.72%-131.14%-5.03%6.99%-40.10%
Profit Margin
-132.24%-170.72%-131.14%-5.03%6.99%-40.10%
FCF Margin
-167.46%-205.78%-48.85%2.10%-19.82%-28.82%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----83.82-
Forward PE
-38.9213.413.90108.00108.00
P/FCF Ratio
---424.69--
PS Ratio
43.0048.7412.168.915.9418.18